Functional advantage after radical segmentectomy versus lobectomy for lung cancer. 2005

Hiroaki Harada, and Morihito Okada, and Toshihiko Sakamoto, and Hidehito Matsuoka, and Noriaki Tsubota
Department of Thoracic Surgery, Hyogo Medical Center for Adults, Akashi, Japan.

BACKGROUND Although several reports have recently demonstrated that segmentectomy for small-sized N0 lung cancer leads to recurrence and survival rates equivalent to those associated with lobectomy, controversy regarding the postoperative functional advantage in the former over the latter still persists. The purpose of this study was to evaluate the degree of postoperative functional loss in patients undergoing segmentectomy or lobectomy for lung cancer. METHODS We analyzed patients able to tolerate lobectomy, who underwent radical segmentectomy (n = 38) or lobectomy (n = 45) for non-small-cell lung cancer. Functional testing included forced vital capacity, forced expiratory volume in 1 second, and anaerobic threshold measured preoperatively and at 2 and 6 months after surgery. RESULTS Preoperative function tests showed no differences between segmentectomy and lobectomy patients. A positive and significant correlation was found between the number of resected segments versus loss of forced vital capacity (r = 0.518, p < 0.0001 at 2 months; r = 0.604, p < 0.0001 at 6 months) and loss of forced expiratory volume in 1 second (r = 0.492, p < 0.0001 at 2 months; r = 0.512, p < 0.0001 at 6 months). The postoperative reduction of forced vital capacity (p = 0.0006) and forced expiratory volume in 1 second (p = 0.0007) was significantly less in the segmentectomy group; however, a marginally significant benefit was observed in this group for anaerobic threshold (p = 0.0616). CONCLUSIONS The extent of removed lung parenchyma directly affected that of postoperative functional loss even at 6 months after surgery, and segmentectomy offered significantly better functional preservation compared with lobectomy. These results indicate the importance of segmentectomy for early staged lung cancer.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011013 Pneumonectomy The excision of lung tissue including partial or total lung lobectomy. Bronchoscopic Lung Volume Reduction,Endoscopic Lung Volume Reduction,Lung Volume Reduction,Lung Volume Reduction Surgery,Partial Pneumonectomy,Partial Pneumonectomies,Pneumonectomies,Pneumonectomy, Partial,Reduction, Lung Volume,Volume Reduction, Lung
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D020127 Recovery of Function A partial or complete return to the normal or proper physiologic activity of an organ or part following disease or trauma. Function Recoveries,Function Recovery

Related Publications

Hiroaki Harada, and Morihito Okada, and Toshihiko Sakamoto, and Hidehito Matsuoka, and Noriaki Tsubota
June 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,
Hiroaki Harada, and Morihito Okada, and Toshihiko Sakamoto, and Hidehito Matsuoka, and Noriaki Tsubota
July 2018, Journal of thoracic disease,
Hiroaki Harada, and Morihito Okada, and Toshihiko Sakamoto, and Hidehito Matsuoka, and Noriaki Tsubota
October 2014, The Journal of thoracic and cardiovascular surgery,
Hiroaki Harada, and Morihito Okada, and Toshihiko Sakamoto, and Hidehito Matsuoka, and Noriaki Tsubota
June 2016, Asian cardiovascular & thoracic annals,
Hiroaki Harada, and Morihito Okada, and Toshihiko Sakamoto, and Hidehito Matsuoka, and Noriaki Tsubota
December 2022, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,
Hiroaki Harada, and Morihito Okada, and Toshihiko Sakamoto, and Hidehito Matsuoka, and Noriaki Tsubota
August 2018, World journal of surgery,
Hiroaki Harada, and Morihito Okada, and Toshihiko Sakamoto, and Hidehito Matsuoka, and Noriaki Tsubota
January 2022, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,
Hiroaki Harada, and Morihito Okada, and Toshihiko Sakamoto, and Hidehito Matsuoka, and Noriaki Tsubota
August 2018, Annals of surgery,
Hiroaki Harada, and Morihito Okada, and Toshihiko Sakamoto, and Hidehito Matsuoka, and Noriaki Tsubota
March 2014, Annals of cardiothoracic surgery,
Hiroaki Harada, and Morihito Okada, and Toshihiko Sakamoto, and Hidehito Matsuoka, and Noriaki Tsubota
September 2015, Asian cardiovascular & thoracic annals,
Copied contents to your clipboard!